Afuco™ Anti-Human CDH5 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-CDH5 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies are humanized antibodies directed that react with human VE-cadherin for use in a human using to inhibit angiogenesis, inhibit tumor metastasis, or treat cell proliferative disorders.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-145CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | CDH5 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤6 months at 4°C; ≥6 months at -20°C. |